Shares of NantKwest, Inc. (NASDAQ:NK) have received an average rating of “Hold” from the seven analysts that are covering the firm. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $17.20.
Several research firms have recently weighed in on NK. Zacks Investment Research downgraded shares of NantKwest from a “buy” rating to a “hold” rating in a research report on Wednesday, January 18th. Jefferies Group LLC downgraded shares of NantKwest from a “buy” rating to a “hold” rating and set a $6.00 target price for the company. in a research report on Tuesday, January 24th.
In related news, Director John C. Thomas sold 6,168 shares of the business’s stock in a transaction dated Friday, November 25th. The shares were sold at an average price of $7.50, for a total transaction of $46,260.00. Following the completion of the sale, the director now owns 309,621 shares of the company’s stock, valued at approximately $2,322,157.50. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John C. Thomas sold 20,000 shares of the business’s stock in a transaction dated Wednesday, November 23rd. The shares were sold at an average price of $7.50, for a total transaction of $150,000.00. Following the sale, the director now directly owns 322,789 shares of the company’s stock, valued at approximately $2,420,917.50. The disclosure for this sale can be found here. 73.06% of the stock is currently owned by insiders.
Large investors have recently made changes to their positions in the stock. State Street Corp increased its stake in shares of NantKwest by 26.8% in the fourth quarter. State Street Corp now owns 193,451 shares of the company’s stock worth $1,105,000 after buying an additional 40,848 shares in the last quarter. Trexquant Investment LP acquired a new stake in shares of NantKwest during the fourth quarter worth $209,000. Emerald Acquisition Ltd. acquired a new stake in shares of NantKwest during the second quarter worth $228,000. Akanthos Capital Management LLC acquired a new stake in shares of NantKwest during the third quarter worth $205,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of NantKwest during the fourth quarter worth $140,000. 24.24% of the stock is owned by institutional investors and hedge funds.
Shares of NantKwest (NASDAQ:NK) traded down 1.54% during midday trading on Friday, reaching $5.11. 89,335 shares of the company were exchanged. The stock’s market capitalization is $420.94 million. The company’s 50-day moving average price is $5.76 and its 200 day moving average price is $6.85. NantKwest has a 52-week low of $4.90 and a 52-week high of $10.30.
This story was originally published by Web Breaking News and is owned by of Web Breaking News. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this story can be read at http://www.webbreakingnews.com/2017/02/17/nantkwest-inc-nk-given-average-rating-of-hold-by-analysts.html.
NantKwest, Inc, formerly Conkwest, Inc, is a biotechnology company engaged in developing targeted direct-acting immunotherapeutic agents for a range of clinical conditions. The Company is focused on harnessing its immune system by using the natural killer (NK) cell to treat cancer, infectious diseases and inflammatory diseases.
Receive News & Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related companies with MarketBeat.com's FREE daily email newsletter.